Kilpatrick Townsend’s Silicon Valley-based start-up team advised the founders of Editas Medicine in the biotech start-up’s $43 million Series A Financing. In a trend setting transaction, venture firms Polaris Partners, Third Rock Ventures, Flagship Ventures and the Partners Innovation Fund invited five of the most prominent research scientists in the field of genomics from MIT, Harvard, the Howard Hughes Medical Institute and the University of California in Berkeley to form a company which they would fund. The money invested will fund the collaborative research and development by this world-class team of scientists as they seek to revolutionize the treatment of genetic disorders by developing a simple, precise and inexpensive method of ‘editing out’ abnormalities in genes in human cells.

Experience Center

Match our Experience to Your Needs

View All Case Studies

Experience Highlights

Convinced DOJ not to take action in a theft of trade secret investigation
In less than three months, we convinced the Department of Justice not to take any action against a client employee for allegedly stealing trade more
Establishment of an U.S. franchise system for Ecowash Mobile
Represented Ecowash Mobile, an Australian car wash franchisor, in the establishment of a franchise system of mobile car washes in the United States. more
Formation and funding for start-up solar power company
Represented start-up solar power company with initial formation and funding. more
Intellectual property protection for one of the world's leading entertainment technology companies
Serves as intellectual property counsel for one of the world's leading entertainment technology companies overseeing protection of intellectual more